DECA DURABOLIN INJ 50MG/ML DIN 00022462
Health Canada record
| Active ingredient(s) | NANDROLONE DECANOATE 50 MG |
|---|---|
| Dosage form | Liquid |
| Route | Intramuscular |
| Schedule | CONTROLLED DRUGS (CDSA IV) |
| Class | Human |
| ATC | A14AB01 NANDROLONE |
| Original market date | 31-Dec-1973 |
| Current status date | 10-Sep-1996 |
| Source | Health Canada DPD |
Establishment licence of the holder
Organon Canada Inc. — licence 3-002674, currently licensed, last inspection rating C (2025-11-06).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NANDROLONE DECANOATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00270687 | DECA DURABOLIN INJ 100MG/ML | SCHERING-PLOUGH CANADA INC | Solution | NANDROLONE DECANOATE 100 MG | Cancelled Post Market |
International API supply for NANDROLONE DECANOATE
1 active FDA Drug Master Files.
Request a quote for DECA DURABOLIN INJ 50MG/ML